Bundesverband der Pharmazeutischen Industrie

Name

Bundesverband der Pharmazeutischen Industrie

Legal name

Bundesverband der Pharmazeutischen Industrie e.V.

Website

https://bpi.de

Company type

Private

Founded year

1951

Operating status

Operating

Headcount range

11–50 employees

Ownership category

akta.pro rank

Product category

Pharmaceutical Industry Trade Association

NAICS

Business Associations (813910)

SIC

Services-Membership Organizations (8600)

akta.pro primary industry

Health, Pharmaceuticals & Medical Devices Regulatory Cooperation (BPADANAJ)

akta.pro secondary industry

Regulatory Strategy & Global Submissions (IND/CTA/NDA/BLA/MAA) (HLAGAKAA)

Keywords

• Pharmaceutical industry advocacy
• Regulatory affairs representation
• Trade association services
• Pharma policy consulting
• Industry member networking

Headquarters

HQ city

Berlin

HQ country

Germany

HQ region

Europe

Offices3 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure

Revenue model

1. Membership dues and fees: BPI generates revenue through membership fees and contributions from its member companies. As a non-profit trade association (eV – eingetragener Verein), revenue is primarily used to fund advocacy, committee operations, publications, events, and member services.

Pricing tiers

Go-to-market motion1 record

Distribution channels4 records

Marketing channels8 records

Core offering

BPI e.V. is a non-profit trade association that represents more than 260 pharmaceutical companies in Germany. Its core offering is industry advocacy, regulatory guidance, and member services delivered through the BPI-Membernet closed portal, six state-level Landesverbände, 18 committees and approximately 50 working groups, a digital publication platform (BPI-Kiosk), recurring publications (Pharmareport, Pharma-Daten, AMNOG-Daten, OTC-Daten), training events such as the Colloquium Pharmaceuticum, the BPIvet veterinary medicines division, and the BPI KonferenzCenter digital event platform.

Product overview

BPI operates as a pharmaceutical industry association offering a portfolio of member services and publications. The core offering includes the BPI-Membernet closed portal for member company employees, the BPI-Kiosk digital publication platform, and the BPIvet veterinary medicines division. Key publications comprise Pharmareport (quarterly magazine), Pharma-Daten (annual statistics), AMNOG-Daten (early benefit assessment data), and OTC-Daten (OTC market data). Training services include Colloquium Pharmaceuticum seminars and the BPI Podcast. The association also operates the BPI KonferenzCenter digital event platform for webinars and conferences.

Differentiator

Problem solved

Functional benefit

Products and services

• BPI-Membernet A closed, login-protected online information and communication platform exclusively for employees of BPI member companies, providing access to committee and working-group team sites plus extended content beyond the public website.
• BPI-Kiosk Digital publication platform hosting BPI reports, position papers, guides, and data publications including Pharmareport, Pharma-Daten, AMNOG-Daten, OTC-Daten, and regional magazines, with archive dating back to 2000.
• BPIvet The BPI specialist department for veterinary medicines, providing a dedicated platform for manufacturers of veterinary medicines and veterinary medical technology products, focusing on industry-specific challenges such as GMP regulations, veterinary pharmacovigilance contracts, and animal health advertising rules.
• Pharmareport Quarterly publication covering pharmaceutical industry developments, health policy, and scientific topics, available in German and English editions through the BPI-Kiosk.
• Pharma-Daten Annual statistical publication containing key industry figures and data on the German pharmaceutical market, available in German and English versions.
• AMNOG-Daten Annual data publication on the AMNOG (Arzneimittelmarktneuordnungsgesetz) early benefit assessment process, tracking pharmaceutical innovation assessment outcomes.
• OTC-Daten Annual publication containing market data and statistics on the German over-the-counter (OTC) pharmaceutical market.
• BPI Podcast Audio content series covering pharmaceutical industry topics, health policy discussions, and BPI activities, available through the Mediathek section of the BPI website.
• Colloquium Pharmaceuticum Continuing-education training events organized by BPI for targeted professional development of employees at member pharmaceutical companies.
• BPI KonferenzCenter Digital event platform powered by Techcast GmbH (accessible at bpi.techcast.cloud) used by BPI to host webinars, online conferences, and digital seminars for members.

Named customers1 record

Segments2 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration7 records

Partnerships

Eight partnerships are on record, tiered core and supporting.

• AKG e.V.coreOthersAKG e.V. (Arbeitskreis Gesundheitswesen) is listed as part of BPI's network of partner organizations. AKG conducts seminars on healthcare communication, compliance, and the EU Pharma Package, with some events organized in cooperation with BPI.
• EUCOPEcoreOthersEUCOPE (European Confederation of Pharmaceutical Entrepreneurs) is listed as part of BPI's network. EUCOPE represents the interests of small and medium-sized pharmaceutical companies at the European level.
• Heacon Service GmbHsupportingStrategic or Co-development PartnerHeacon Service GmbH is listed as a BPI network partner providing consulting services that complement BPI's member offerings. BPI explicitly mentions Heacon as a source of 'specific consulting' for members.
• Pharma AuditsupportingOthersPharma Audit is part of the BPI network of partner organizations, providing audit-related services to the pharmaceutical industry.
• pharmaplace AGsupportingOtherspharmaplace AG is listed as part of BPI's partner network, providing industry-specific services to pharmaceutical companies.
• Rote Liste Service GmbHcoreOthersRote Liste Service GmbH is a BPI network partner providing the well-known Rote Liste (Red List) drug information database used throughout the German pharmaceutical and healthcare sector.
• BPI ServicesupportingOthersBPI Service is listed as a BPI network partner, providing services that support the association's member offerings.
• Verband der Chemischen Industrie (VCI)coreStrategic or Co-development PartnerBPI co-organizes the annual Infotag Patentrecht (Patent Law Information Day) with VCI, along with the Verband Forschender Arzneimittelhersteller (vfa) and law firm Taylor Wessing. This is a joint event covering patent law developments and case law.

Scale indicators4 records

Recent moves6 records

Expansion highlights5 records

Regional players

• JPMA (Japan Pharmaceutical Manufacturers Association): The Japanese pharmaceutical industry trade association. Functionally analogous to BPI as a national pharma industry body, with a similar mandate to represent members in policy and regulatory affairs.
• ABPI (Association of the British Pharmaceutical Industry): The UK pharmaceutical industry trade association. Operates the same industry-body model as BPI but represents the UK pharma sector, with analogous advocacy, policy, and member-services activities.

Broad incumbents

• Medicines for Europe: European association representing generic, biosimilar, and value-added medicines manufacturers. Comparable to BPI in its industry-body model but with a generics-focused mandate at EU level.
• PhRMA (Pharmaceutical Research and Manufacturers of America): The US pharmaceutical industry association. Operates the same trade-association model as BPI but at vastly larger scale, representing research-based pharma companies in the United States.
• EFPIA (European Federation of Pharmaceutical Industries and Associations): The pan-European pharma industry association covering research-based companies. Operates at a broader scope than BPI but addresses overlapping regulatory and policy issues across the EU pharmaceutical value chain.
• IFPMA (International Federation of Pharmaceutical Manufacturers and Associations): The global pharma industry association representing research-based companies and associations worldwide. Operates at a broader international level than BPI but addresses similar policy and advocacy issues.

Direct peers

• Pro Generika: German trade association for generics manufacturers. Like BPI, it is a pharma industry body advocating for its segment, and competes for German pharma membership and policy influence.
• EUCOPE (European Confederation of Pharmaceutical Entrepreneurs): European-level association for small and medium-sized pharmaceutical companies. Overlaps with BPI's mission at the EU level and is even a BPI network partner, but competes for SME pharma representation mandate in Brussels.
• AKG e.V. (Arbeitskreis Gesundheitswesen): BPI's network partner focused on healthcare communication and compliance training for the pharma sector. Comparable industry-body actor operating in the same German pharma compliance and policy education space as BPI.
• Verband Forschender Arzneimittelhersteller (vfa): The leading German pharmaceutical industry association representing research-based pharma companies. Direct competitor to BPI for member companies and political influence, with a focus on innovative prescription medicines rather than the broader SME market that BPI serves.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/bundesverband-der-pharmazeutischen-industrie
• Xx.com/bpi_pharma

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Bundesverband der Pharmazeutischen Industrie